BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 20386523)

  • 1. Anaplastic thyroid carcinoma. Practical aspects of multimodal therapy and data emerging from a 40-year experience at a single Italian institution.
    Baroli A; Pedrazzini L; Lomuscio G; Marzoli L
    Minerva Endocrinol; 2010 Mar; 35(1):9-16. PubMed ID: 20386523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapy of stage IV B anaplastic thyroid carcinoma: single institution experience.
    Vrbic S; Pejcic I; Vrbic M; Filipovic S
    J BUON; 2009; 14(1):41-4. PubMed ID: 19373945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anaplastic thyroid cancer: prevalence, diagnosis and treatment.
    Chiacchio S; Lorenzoni A; Boni G; Rubello D; Elisei R; Mariani G
    Minerva Endocrinol; 2008 Dec; 33(4):341-57. PubMed ID: 18923370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anaplastic thyroid carcinoma: a 50-year experience at a single institution.
    McIver B; Hay ID; Giuffrida DF; Dvorak CE; Grant CS; Thompson GB; van Heerden JA; Goellner JR
    Surgery; 2001 Dec; 130(6):1028-34. PubMed ID: 11742333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Completely resected anaplastic thyroid carcinoma combined with adjuvant chemotherapy and irradiation is associated with prolonged survival.
    Haigh PI; Ituarte PH; Wu HS; Treseler PA; Posner MD; Quivey JM; Duh QY; Clark OH
    Cancer; 2001 Jun; 91(12):2335-42. PubMed ID: 11413523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment outcomes in anaplastic thyroid carcinoma: survival improvement in young patients with localized disease treated by combination of surgery and radiotherapy.
    Yau T; Lo CY; Epstein RJ; Lam AK; Wan KY; Lang BH
    Ann Surg Oncol; 2008 Sep; 15(9):2500-5. PubMed ID: 18581185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel chemo-radiotherapy with low-dose daily cisplatin, 5-fluorouracil and doxorubicin for anaplastic thyroid carcinoma: a preliminary report.
    Tanaka K; Sugitani I; Fujimoto Y
    Jpn J Clin Oncol; 2011 Sep; 41(9):1074-8. PubMed ID: 21791572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Differential diagnosis and strategy for the treatment of anaplastic thyroid carcinoma].
    Suzuki S
    Nihon Rinsho; 2007 Nov; 65(11):2079-86. PubMed ID: 18018574
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anaplastic thyroid carcinoma: comparison of conventional radiotherapy and hyperfractionation chemoradiotherapy in two groups.
    Heron DE; Karimpour S; Grigsby PW
    Am J Clin Oncol; 2002 Oct; 25(5):442-6. PubMed ID: 12393980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Undifferentiated carcinoma of the thyroid gland].
    Busnardo B; Girelli ME; Nacamulli D; Pelizzo MR; Daniele O; Rigon A
    Chir Ital; 1994; 46(4):37-41. PubMed ID: 7533667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surgical treatment of anaplastic thyroid carcinoma. Our experience.
    Palestini N; Brignardello E; Freddi M; Piovesan A; Pipitone Federico NS; Sisto G; Robecchi A
    G Chir; 2010; 31(6-7):282-5. PubMed ID: 20646371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemosensitivity of anaplastic thyroid carcinoma and poorly differentiated thyroid carcinoma.
    Asakawa H; Kobayashi T; Komoike Y; Maruyama H; Nakano Y; Tamaki Y; Matsuzawa Y; Monden M
    Anticancer Res; 1997; 17(4A):2757-62. PubMed ID: 9252711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjuvant fractionated high-dose-rate intracavitary brachytherapy after external beam radiotherapy in Tl and T2 nasopharyngeal carcinoma.
    Lu JJ; Shakespeare TP; Tan LK; Goh BC; Cooper JS
    Head Neck; 2004 May; 26(5):389-95. PubMed ID: 15122654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of primary treatment on survival in anaplastic thyroid carcinoma.
    Besic N; Auersperg M; Us-Krasovec M; Golouh R; Frkovic-Grazio S; Vodnik A
    Eur J Surg Oncol; 2001 Apr; 27(3):260-4. PubMed ID: 11373102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anaplastic thyroid carcinoma. Treatment outcome and prognostic factors.
    Kebebew E; Greenspan FS; Clark OH; Woeber KA; McMillan A
    Cancer; 2005 Apr; 103(7):1330-5. PubMed ID: 15739211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anaplastic thyroid carcinoma: a case of a young women that reports a survival exceeding 6 years.
    Batori M; Chatelou E; Straniero A; Ruggieri M
    Eur Rev Med Pharmacol Sci; 2007; 11(1):69-71. PubMed ID: 17405351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined treatment of anaplastic thyroid carcinoma with surgery, chemotherapy, and hyperfractionated accelerated external radiotherapy.
    De Crevoisier R; Baudin E; Bachelot A; Leboulleux S; Travagli JP; Caillou B; Schlumberger M
    Int J Radiat Oncol Biol Phys; 2004 Nov; 60(4):1137-43. PubMed ID: 15519785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment and prognosis of anaplastic thyroid carcinoma].
    Sun CZ; Chen FJ; Zeng ZY; Chen YF; Li QL; Guan Z; Tian SZ
    Zhonghua Wai Ke Za Zhi; 2006 Nov; 44(21):1493-7. PubMed ID: 17349179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adrenocortical carcinoma. Our experience.
    Favia G; Lumachi F; Carraro P; D'Amico DF
    Minerva Endocrinol; 1995 Mar; 20(1):95-9. PubMed ID: 7651289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management and outcome of recurrent well-differentiated thyroid carcinoma.
    Palme CE; Waseem Z; Raza SN; Eski S; Walfish P; Freeman JL
    Arch Otolaryngol Head Neck Surg; 2004 Jul; 130(7):819-24. PubMed ID: 15262757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.